DongKoo Bio & Pharma Co., Ltd. (KOSDAQ: 006620)
South Korea
· Delayed Price · Currency is KRW
5,040.00
-20.00 (-0.40%)
Jan 22, 2025, 3:00 PM KST
DongKoo Bio & Pharma Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2017 | 2016 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '17 Dec 31, 2017 | 2016 - 2015 |
Net Income | 15,337 | 11,812 | 6,614 | 9,327 | 9,140 | 10,943 | Upgrade
|
Depreciation & Amortization | 6,684 | 6,028 | 5,632 | 5,054 | 4,506 | 2,207 | Upgrade
|
Loss (Gain) From Sale of Assets | -5.98 | 0 | -123.89 | 1.33 | 81.62 | -0.33 | Upgrade
|
Asset Writedown & Restructuring Costs | 300 | - | - | 0 | - | - | Upgrade
|
Loss (Gain) From Sale of Investments | -8,701 | -2,077 | 8,869 | -1,090 | -1,985 | -68.17 | Upgrade
|
Loss (Gain) on Equity Investments | 3,977 | 660.61 | -118.28 | 1,733 | -726.96 | 528.35 | Upgrade
|
Stock-Based Compensation | 257.97 | 224.51 | - | - | - | 243.63 | Upgrade
|
Provision & Write-off of Bad Debts | -120.34 | -52.82 | 40.44 | 241.76 | 1,370 | 417.54 | Upgrade
|
Other Operating Activities | 6,196 | 1,697 | 331.91 | 638.04 | 1,744 | 1,690 | Upgrade
|
Change in Accounts Receivable | -1,443 | -1,333 | -2,861 | 1,431 | 1,532 | -5,771 | Upgrade
|
Change in Inventory | -2,750 | -12,838 | -6,686 | -1,897 | -7,192 | -1,561 | Upgrade
|
Change in Accounts Payable | -4,825 | -3,093 | 2,715 | 2,399 | -2,040 | 969.88 | Upgrade
|
Change in Other Net Operating Assets | 4,072 | 2,558 | 2,404 | 65.1 | 1,058 | -92.24 | Upgrade
|
Operating Cash Flow | 18,978 | 3,585 | 16,819 | 17,903 | 7,489 | 9,507 | Upgrade
|
Operating Cash Flow Growth | 57.00% | -78.68% | -6.05% | 139.06% | -21.23% | -24.47% | Upgrade
|
Capital Expenditures | -26,134 | -13,845 | -4,978 | -4,266 | -5,268 | -810.51 | Upgrade
|
Sale of Property, Plant & Equipment | 6 | 0.66 | 300.44 | 11.97 | - | - | Upgrade
|
Sale (Purchase) of Intangibles | -3,835 | -2,034 | -6,098 | -1,137 | -192.72 | -8.48 | Upgrade
|
Investment in Securities | -4,977 | 11,851 | -16,287 | 6,202 | -6,072 | -971.17 | Upgrade
|
Other Investing Activities | 523.28 | -106 | 39 | -366.43 | -1,059 | 16.09 | Upgrade
|
Investing Cash Flow | -35,955 | -5,133 | -27,014 | 463.93 | -12,564 | -1,774 | Upgrade
|
Short-Term Debt Issued | - | 7,500 | 15,000 | 70.75 | 10,000 | 6,290 | Upgrade
|
Long-Term Debt Issued | - | 1,447 | - | - | - | - | Upgrade
|
Total Debt Issued | 45,218 | 8,947 | 15,000 | 70.75 | 10,000 | 6,290 | Upgrade
|
Short-Term Debt Repaid | - | - | - | - | -6,883 | -9,230 | Upgrade
|
Long-Term Debt Repaid | - | -1,126 | -5,966 | -742.12 | -2,536 | -1,215 | Upgrade
|
Total Debt Repaid | -9,292 | -1,126 | -5,966 | -742.12 | -9,419 | -10,445 | Upgrade
|
Net Debt Issued (Repaid) | 35,926 | 7,821 | 9,034 | -671.37 | 581.47 | -4,155 | Upgrade
|
Issuance of Common Stock | - | - | - | - | - | 1,402 | Upgrade
|
Repurchase of Common Stock | -3,079 | -79.9 | -2,995 | -1,998 | - | - | Upgrade
|
Dividends Paid | -3,313 | -3,038 | -2,804 | -942.94 | -942.92 | - | Upgrade
|
Other Financing Activities | 1,545 | 49 | -50 | -76.1 | 0 | - | Upgrade
|
Financing Cash Flow | 31,079 | 4,752 | 3,185 | -3,688 | -361.45 | -2,753 | Upgrade
|
Foreign Exchange Rate Adjustments | -85.85 | -4.74 | -33.91 | -2.27 | -23.18 | -0 | Upgrade
|
Miscellaneous Cash Flow Adjustments | - | - | 0 | -0 | -0 | 0 | Upgrade
|
Net Cash Flow | 14,016 | 3,199 | -7,043 | 14,676 | -5,460 | 4,980 | Upgrade
|
Free Cash Flow | -7,156 | -10,260 | 11,841 | 13,637 | 2,221 | 8,696 | Upgrade
|
Free Cash Flow Growth | - | - | -13.17% | 514.06% | -74.46% | 44.13% | Upgrade
|
Free Cash Flow Margin | -2.82% | -4.76% | 6.07% | 8.79% | 1.60% | 8.60% | Upgrade
|
Free Cash Flow Per Share | -260.75 | -371.44 | 426.63 | 482.57 | 78.50 | 387.18 | Upgrade
|
Cash Interest Paid | 2,446 | 1,672 | 902.19 | 362.76 | 401.35 | 484.24 | Upgrade
|
Cash Income Tax Paid | 3,509 | 4,104 | 3,076 | 1,392 | 730.99 | 1,254 | Upgrade
|
Levered Free Cash Flow | -12,064 | -15,354 | -140.43 | 10,027 | - | 4,462 | Upgrade
|
Unlevered Free Cash Flow | -10,501 | -14,254 | 509.14 | 10,286 | - | 4,821 | Upgrade
|
Change in Net Working Capital | -1,292 | 13,685 | 4,571 | -5,549 | - | 5,149 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.